Kapa3 actively participated in the conference “Mapping the Unknown in Oncology – From Hospitals to Homes, mapping the future of oncology care”, organized for its third year by the Medical Society for Research and Education under the auspices of HeSMO (Hellenic Society of Medical Oncologists) and the Hellenic Cancer Society, held on February 27–28, 2026 at the Golden Age Hotel in Athens.
During the events on Saturday, February 28, Ms. Evangelí Bista, Head of Operations and Development at the Kapa3 Cancer Patient Guidance Center, took part in the panel titled “e-Health Tools and Educational Platforms: New Paths for Doctors and Patients.” The panel was moderated by Ms. Z. Saridaki and included panelists G. Koukourakis, S. Peroukidis, F. Tyligadas, and Ch. Christodoulou.
In her presentation, titled “Digital Patient Education: The Patient as an Active Partner,” Ms. Bista highlighted the importance of digital transformation in healthcare, which shifts care from episodic to continuous support, moving healthcare from hospitals into patients’ daily lives and empowering patients to become active participants in managing their health.
In this context, Kapa3 announced that for 2026 it will be the only civil society organization fully integrating AI, cybersecurity, and high-performance computing into its processes and services, implementing:
-
An AI-powered digital assistant (chatbot) for immediate patient guidance and support
-
A voice-command system for website accessibility and text-to-speech conversion
-
Service redesign, simplifying processes and reducing bureaucracy
-
An AI-based recommendation system with usage data analysis to personalize services
Special emphasis was placed on patient navigation, as oncology patients need guidance: where to go, what they are entitled to, when to be concerned, and when to wait. Kapa3 addresses this gap, providing not just information but meaningful, personalized guidance within the healthcare system.
The goal is not to add another service but to unite existing services. The next evolution of this model is Myrto, the digital assistant that serves as a reference point, translating knowledge into daily action.
Because the future of oncology is not only personalized treatment but also personalized understanding.
Kapa3’s participation underscores the organization’s commitment to innovation, collaboration, and ethics, demonstrating how technology can significantly enhance the experience and care of oncology patients.
